319 related articles for article (PubMed ID: 27925871)
41. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
[TBL] [Abstract][Full Text] [Related]
42. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
[TBL] [Abstract][Full Text] [Related]
44. Dentate Nucleus Signal Intensity Changes in Children with Adrenoleukodystrophy in Comparison to Primary Brain Tumor with and without Radiotherapy after Gadobutrol Administration.
Ozturk K; Nascene D
J Neuroimaging; 2021 May; 31(3):602-608. PubMed ID: 33783925
[TBL] [Abstract][Full Text] [Related]
45. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
[TBL] [Abstract][Full Text] [Related]
46. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
[TBL] [Abstract][Full Text] [Related]
47. MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study.
Choi Y; Jang J; Kim J; Nam Y; Shin NY; Ahn KJ; Jeon SS; Kim BS
Radiology; 2020 Oct; 297(1):143-150. PubMed ID: 32692298
[TBL] [Abstract][Full Text] [Related]
48. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
[TBL] [Abstract][Full Text] [Related]
49. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
[TBL] [Abstract][Full Text] [Related]
50. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
[TBL] [Abstract][Full Text] [Related]
51. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
Ichikawa S; Omiya Y; Onishi H; Motosugi U
J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
[TBL] [Abstract][Full Text] [Related]
52. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
[TBL] [Abstract][Full Text] [Related]
53. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
[TBL] [Abstract][Full Text] [Related]
54. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.
Zhang Y; Cao Y; Shih GL; Hecht EM; Prince MR
Radiology; 2017 Feb; 282(2):516-525. PubMed ID: 27513848
[TBL] [Abstract][Full Text] [Related]
55. Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
Splendiani A; Corridore A; Torlone S; Martino M; Barile A; Di Cesare E; Masciocchi C
Insights Imaging; 2019 Sep; 10(1):82. PubMed ID: 31482392
[TBL] [Abstract][Full Text] [Related]
56. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
[TBL] [Abstract][Full Text] [Related]
57. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
[TBL] [Abstract][Full Text] [Related]
58. Gadolinium Deposition within the Pediatric Brain: No Increased Intrinsic T1-Weighted Signal Intensity within the Dentate Nucleus following the Administration of a Minimum of 4 Doses of the Macrocyclic Agent Gadoteridol.
Young JR; Pope WB; Bobinski M
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1604-1608. PubMed ID: 30093477
[TBL] [Abstract][Full Text] [Related]
59. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
[TBL] [Abstract][Full Text] [Related]
60. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
